Skip to Content

Mission Statement

What are iNKT cells?

Solid Tumour Strategies

Publications & Conference Proceedings

ALA-101: CAR19-iNKT

ALA-105: CLDN18.2-iNKT

Investor Centre

ASX Announcements

News & Presentations

Financial Reports

Analyst Coverage

Mission Statement

What are iNKT cells?

Solid Tumour Strategies

Publications & Conference Proceedings

ALA-101: CAR19-iNKT

ALA-105: CLDN18.2-iNKT

Investor Centre

ASX Announcements

News & Presentations

Financial Reports

Analyst Coverage

Mission Statement

Folder: Technology

What are iNKT cells?

Solid Tumour Strategies

Publications & Conference Proceedings

Folder: Products

ALA-101: CAR19-iNKT

ALA-105: CLDN18.2-iNKT

Folder: Investors

Investor Centre

ASX Announcements

News & Presentations

Financial Reports

Analyst Coverage

News & Presentations

Filter by Category

All 59
Company News 21
Media 14
Newsletter 7
Presentations & Webinars 18

Arovella completes $4m placement & launches $1m SPP

Company News, All Michelle Long 11/7/23 Company News, All Michelle Long 11/7/23

Arovella completes $4m placement & launches $1m SPP

Read More

investor@arovella.com
+61.3.9863.6472

Subscribe to our Newsletters

Email Address

Thank you for joining the database for Arovella Therapeutics - we will contact you with upcoming investor relation news.

Site by BDAC Media